MENU
DEC 9 - 10 2020 Opens: 3:00 AM EST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Drug Discovery and Development

Accelerate Your Drug Discoveries with Live Cell Analysis

As the cost of bringing new drugs to market continues to grow, so do the pressures around increasing efficiency and productivity throughout the discovery and development cycle. And, no matter the stage, cell based analysis plays a critical role whether that be in discovery stages where you're identifying new potential targets, in screening where you're modifying the target, or in toxicity studies where you're examining adverse effects on targets. 

Join us for our two-day Agilent Cell Analysis Drug Discovery and Development live conference. Agilent, and BioTek, the newest member of the Agilent family, will be showcasing their latest innovations in cell analysis for drug discovery research including interactive booths, scientific posters and live chat with product experts. There will also be a series of presentations from industry leaders who will discuss how they’ve adopted cell-based assays in their work to increase efficiency and productivity across:

  • Target identification and validation
  • Screening
  • Cardiosafety and mitochondrial toxicity studies
  • Biologics stability and ADME toxicology
     

Discover how leading researchers worldwide are conducting novel research in drug discovery and development, and how Agilent provides key technologies and solutions to advance their therapeutic opportunities through the different stages of drug development:
 

  • Seahorse XF technology measures the two major metabolic pathways, glycolysis and mitochondrial respiration, for live cells in real-time allowing you to expand your drug discovery pipeline by targeting these pathways, assessing compounds for mitochondrial toxicity, and better understanding their mechanisms.
     
  • Soluble Metabolic Sensors MitoXpress & pH-Xtra Products provide a high throughput, mix-and-measure, plate reader assessment of mitochondrial function and cell metabolism for investigating microbial metabolism, screening for antimicrobial compounds, as well as Anti-parasitic drug screening and drug target discovery.
     
  • Identify cardiotoxic effects by monitoring contractile, structural, and ion channel activity in real time using the xCELLigence real-time cell analysis (RTCA) Cardio/CardioECR/ePacer systems.
     
  • NovoCyte flow cytometers provide robust, sensitive and automated quantitative assays relevant to drug discovery and development such as immunophenotyping and cell cycle analysis.
     
  • Synergy Neo2 Multi-Mode Microplate Reader provides sensitivity and speed for biochemical and cell-based screening applications.
     
  • A wide range of microplate dispensing and washing products including EL406 Combination Washer Dispenser, 405 LS Microplate Washer and MultiFlo FX Multi-Mode Dispenser delivers high precision, cost-effective benchtop automation for any level of sample throughput in screening, lead optimization and ADME/Tox applications.
     
  • The Cytation platform combines microplate reader optics with automated digital widefield microscopy coupled with a broad range of quantitative image analysis metrics.  Designed specifically to enable both target-based and phenotypic cell-based assays, with either fixed or live cells, Cytation is ready for any assay. 

For Research Use Only. Not for use in diagnostic procedures.


Speakers
  • Staff Scientist, Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
  • Associate Professor of Biophysics, University of Bath; Director, BLOC Laboratories Ltd
  • Co Founder, CSO at SyntheX, Inc.
  • Associate Dean for Research, Endowed Professor in Mitochondrial Medicine and Pathology, University of Alabama at Birmingham
  • Senior Scientist, Immunotherapy, Pre-clinical Development, Elevatebio
  • Principal Scientist, Gilead Sciences, Inc.

Show Resources
You May Also Like
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
FEB 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
FEB 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 10th annual Laboratory Animal Science (LAS) Virtual Conference which will take place on February 10th 2021. This is the premier on...
MAY 19, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAY 19, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Welcome to the 5th Annual Laboratory Automation & Informatics Virtual Event ; a free virtual conference for professionals interested in the most recent technologies for today’s la...
MAR 24, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAR 24, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 4th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 24, 2021. The Cannabis Sciences planning committee will be plannin...
DEC 03, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
DEC 03, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
A novel coronavirus emerged in China in late 2019; it has since been dubbed 2019-nCoV. LabRoots will be working to educate the community about this pathogen in an ongoing series of virtual ev...
Speakers

  • Emily Dunkelberger, PhD
    Staff Scientist, Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
    Biography
      Dr. Emily Dunkelberger is a Staff Scientist in the Laboratory of Chemical Physics in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. Dr. Dunkelberger came to the NIH in 2013 after completing her PhD in Physical Chemistry with Professor Martin Zanni at the University of Wisconsin-Madison. There she used two-dimensional infrared spectroscopy and isotope labeling to study protein folding and aggregation. Her work contributed to the understanding of how human amylin misfolds into amyloid beta sheet fibers in Type II diabetics. As part of her graduate work, she also tested multiple potential small molecules and peptides for inhibiting amyloid fiber growth in amylin. Since arriving at the NIH as a Research Fellow, Dr. Dunkelberger has studied the biophysics of sickle cell disease. Currently, she works on a team that developed a high-throughput drug screen that has been used to screen a library of more than 12,000 compounds. She also collaborates with clinicians in other NIH institutes on sickle cell mouse studies and on-going clinical trials. Beyond assay development and testing, Dr. Dunkelberger served on the Intramural Training and Education Career Symposium committee and she mentors rotating post-baccalaureates in the lab.
    • Chris Pudney, PhD
      Associate Professor of Biophysics, University of Bath; Director, BLOC Laboratories Ltd
      Biography
        Dr Pudney read Biochemistry at the University of Bath, with research at the Albert Einstein School of Medicine (NY, USA), graduating with a first class honours degree in 2005. Pudney’s PhD research at the University of Manchester (graduated 2008) involved studying quantum mechanical phenomena in enzyme catalysis. Post-doctoral work at Manchester was based on developing fluorescence approaches to track enzyme activity, including time resolved conformational changes and at the single molecule level. Pudney became an Assistant Professor at the University of Bath in 2013 and Associated Professor in 2018. His lab is focussed on understanding the functional importance of protein dynamics and conformational change and developing new analytical tools. Notable advances are approaches for predicting protein stability (DOI:10.1042/BCJ20200580) and the point-of-care detection of Novel Psychoactive Substances (DOI:10.1021/acs.analchem.9b03037). In 2019, Pudney Span-out a company (BLOC Laboratories) to commercialise the QUBES stability prediction technology. The approach is implemented in a software package, which is commercially available in Q3 2020.
      • Charly Chahwan, PhD
        Co Founder, CSO at SyntheX, Inc.
        Biography
          Charly Chahwan is the co-founder and CSO of SyntheX. After completing his HBSc degree in Physiology and Biophysics at the University of Toronto, Charly joined the department of Molecular Biology at the Scripps Research Institute in California. During his 5 years at Scripps, Charly's studies were focused on molecular mechanisms of cell cycle and checkpoint control, DNA repair pathways, and genomic stability in healthy and cancer cells. After Scripps, Charly joined the PhD program at the Department of Molecular Genetics at the University of Toronto and continued studying additional mechanisms that control genomic stability, aneuploidy, and the faithful transmission of chromosomes. He was awarded multiple governmental grants and set up independent collaborations with scientists in North America and Europe, resulting in over 20 peer-reviewed publications. Following years of research in molecular biology and genetics, Charly was eager to bring ground-breaking research from the bench to bedside. During the past 4 years as CSO of SyntheX, Charly ha  been focused on pushing forward the STX100 program towards the clinic and has spearheaded the development of the ToRPPIDO and ToRNeDO platforms. These platforms are the discovery engines that feed SyntheX's pipeline, which is predominantly focused on targets that were previously deemed to be undruggable.
        • Victor Usmar-Darley, PhD
          Associate Dean for Research, Endowed Professor in Mitochondrial Medicine and Pathology, University of Alabama at Birmingham
        • Sandra Milasta, PhD
          Senior Scientist, Immunotherapy, Pre-clinical Development, Elevatebio
        • Joy Feng, PhD
          Principal Scientist, Gilead Sciences, Inc.
          Biography
            Joy Feng is a Principal Scientist at Gilead Sciences, Inc. She has a Ph.D. degree in Medicinal Chemistry from the University of Florida. During her postdoc training at Dr. Karen Anderson's lab at Yale, Joy developed her deep appreciation of mitochondria while studying drug-induced mitochondrial toxicity using an enzymatic approach. At Gilead, Joy continues probing drug-induced mitochondrial toxicity. In addition to studying mitochondrial enzymes, she also uses mitochondrial protein synthesis, cellular respiration, and other parameters to evaluate mitochondria toxicity. She has used these approaches successfully assessed  mitochondria toxicity liability for multiple approved antiviral agents for HIV, HCV, and most recently COVID-19.
          About Us

          Agilent is a global leader in life science, diagnostics, and analytical laboratory technologies. Now growing in the cell analysis space, Agilent instruments, software, services, solutions, and people provide trusted answers to our customers' most challenging questions.

          What started as a unique offering of solutions focused on understanding cellular functionality based on underlying metabolic programming has transformed into a set of innovative tools with the additions of ACEA Biosciences and BioTek Instruments – providing customers the tools they need to uncover unique cell biology, discover novel drug targets, improve preclinical in vitro toxicology, and pioneer the next generation of immunotherapies.

          Explore a breadth of solutions in real-time, impedance-based analysis of cell function, real-time cell metabolism, cell imaging and microscopy, microplate readers, microplate washers, flow cytometers, and more.
           
          For Research Use Only. Not for use in diagnostic procedures.

          Help

          General LabRoots Questions

          email support@labroots.com  

          Virtual Events and Webinars

          Supported Configurations

          • Operating System Internet Explorer Firefox Chrome Safari
            Vista IE8+ FF10+ Chrome15+
            Windows 7 IE8+ FF10+ Chrome15+
            Windows 8 IE10 FF10+ Chrome15+
            Mac OS X   FF10+ Chrome15+ Safari5.1+
          • Cookie settings: session cookies enabled
          • Browser configuration must have JavaScript enabled
          • Adobe Flash player 10.2 or later

          To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

          Internet Connection

          • A minimum of 100Kbps is recommended for audio-only events
          • A minimum of 300Kbps is recommended for speaker on-video events

          Computer Equipment

          • Screen Resolution: Minimum 1024x768
          • Video Card: 65,000 colors minimum
          • Sound card and speakers (or headphones) for hearing webcast in full format
          • Audio Card: 16-bit minimum
          • RAM: 512MB of free RAM

          Firewall Protocol

          • HTTP on port 80 or HTTPS on port 443
          • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
          • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

          Work-At-Home Attendees

          • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

          For A Seamless Experience

          When using a mobile device, FREE Mobile Apps are available:

          - For viewing Webinars:

          - For viewing Virtual Events

          Attendee Guide

          • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

          Virtual Event and Webinar Support:

          Continuing Education (CME/CE) Support

          Loading Comments...
          Show Resources
          Event Countdown
          • 0 Days
          • 0 Hours
          • 0 Minutes
          • 0 Seconds
          Attendees
          • See more